If your body reacts poorly, if your dose shouldn't rise yet, or if another treatment makes more sense, a clinician can act on that information
For the investigation, a team led by Al-Aly sifted through the records of nearly 2 million people with diabetes who were treated by the Veterans Health Administration for an average of almost four years between October 2017 and the end of December 2023
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomized, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
References: 1
Uma abordagem essencial para o tratamento do DM2 envolve conscientizar o indivduo sobre sua condio, ajudando-o a compreender o que o diabetes, suas causas e como ele pode contribuir para o agravamento de outras patologias